VBI Vaccines Inc - ESG Rating & Company Profile powered by AI
The ESG rating includes seventeen United Nations SDGs including: 'Gender Equality', 'Decent Work & Economic Growth' and 'Life on Land'. This page displays a free Environmental, Social and Governance analysis covering VBI Vaccines Inc. This analysis of VBI Vaccines Inc was assembled by All Street Sevva using cutting edge machine learning.
VBI Vaccines Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 1.1, social score of 1.1 and governance score of 1.3.
1.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
| 1755 | Trimurthi Ltd | 1.3 | Low |
| 1779 | VBI Vaccines Inc | 1.2 | Low |
| 1779 | Cell Biotech Co Ltd | 1.2 | Low |
| 1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does VBI Vaccines Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes VBI Vaccines Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes VBI Vaccines Inc report the average age of the workforce?
Sign up for free to unlockDoes VBI Vaccines Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes VBI Vaccines Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes VBI Vaccines Inc disclose cybersecurity risks?
Sign up for free to unlockDoes VBI Vaccines Inc offer flexible work?
Sign up for free to unlockDoes VBI Vaccines Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes VBI Vaccines Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes VBI Vaccines Inc conduct supply chain audits?
Sign up for free to unlockDoes VBI Vaccines Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes VBI Vaccines Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes VBI Vaccines Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes VBI Vaccines Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes VBI Vaccines Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes VBI Vaccines Inc disclose water use targets?
Sign up for free to unlockDoes VBI Vaccines Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid VBI Vaccines Inc have a product recall in the last two years?
Sign up for free to unlockDoes VBI Vaccines Inc disclose incidents of discrimination?
Sign up for free to unlockDoes VBI Vaccines Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas VBI Vaccines Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes VBI Vaccines Inc disclose parental leave metrics?
Sign up for free to unlockDoes VBI Vaccines Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes VBI Vaccines Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes VBI Vaccines Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes VBI Vaccines Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes VBI Vaccines Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes VBI Vaccines Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs VBI Vaccines Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes VBI Vaccines Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes VBI Vaccines Inc disclose its waste policy?
Sign up for free to unlockDoes VBI Vaccines Inc report according to TCFD requirements?
Sign up for free to unlockDoes VBI Vaccines Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes VBI Vaccines Inc disclose energy use targets?
Sign up for free to unlockDoes VBI Vaccines Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes VBI Vaccines Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for VBI Vaccines Inc
These potential risks are based on the size, segment and geographies of the company.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.